Oct 2026· Engineering, Technology & Applied Science Research· Vol 16, pp. 39804-39811· 0 citations· 29 references
TL;DR
This study proposes a lightweight dual-task framework for simultaneous malignancy classification and fuzzy severity estimation using paired Cranio-Caudal and Medio-Lateral Oblique views along with patient metadata, based on an EfficientNet-B0 backbone with dual-view fusion and metadata integration.
Abstract
Early detection of breast cancer is crucial for improving survival, with mammography serving as the primary screening tool despite challenges such as tissue overlap, subtle lesions, and breast density variation. Although deep learning has improved automated analysis, most existing methods focus on binary classification and single-view imaging, with limited use of clinical metadata or joint malignancy classification and fuzzy severity estimation frameworks. This study proposes a lightweight dual-task framework for simultaneous malignancy classification and fuzzy severity estimation using paired Cranio-Caudal (CC) and Medio-Lateral Oblique (MLO) views along with patient metadata. A structured preprocessing pipeline enhances data reliability through CC–MLO pairing, normalization, resizing, and memory-efficient loading. The model is based on an EfficientNet-B0 backbone with dual-view fusion and metadata integration, trained using a two-phase fine-tuning strategy and fuzzy severity encoding. Experiments on 7,808 images from the Mini-DDSM dataset achieved 97.83% accuracy and 0.98 ROC–AUC, with severity-level ROC–AUC values ranging from 0.90 to 0.96. Comparative results against ResNet50, DenseNet121, and Vision Transformer (ViT) showed improved performance with lower computational cost. The proposed framework integrates multi-view imaging, metadata, and fuzzy severity estimation within a unified lightweight architecture for efficient and reliable computer-aided breast cancer screening.
By combining precise lesion segmentation, lightweight classification, and cross data validation, this work demonstrates a segmentation guided approach for breast cancer classification, that may be explored further for successful integration in computer-aided diagnostic systems.
Early detection of breast cancer is essential for improving patient survival and reducing mortality. Although histopathology-based diagnosis provides definitive clinical evidence, the complex and heterogeneous nature of breast cancer histopathology (BCH) images poses significant challenges for accurate classification....
BackgroundBreast cancer remains a major global health concern, and early and accurate detection is critical for improving clinical outcomes. However, variations in lesion characteristics and imaging conditions in Digital Breast Tomosynthesis (DBT) images present substantial challenges for automated breast tumor classif...
Sridevi Rajalingam, Kavitha Maruthai· Technology and Health Care· 0 citations
Summary Accurate discrimination of benign and malignant breast lesions is essential for early diagnosis, yet remains challenging due to lesion heterogeneity and interobserver variability in ultrasound assessment. We developed a deep learning (DL) framework integrating dual inverted bottleneck blocks (Dual-IB), adaptive...
Tao Hu, Rong-Rong Ru, Ying-Ying Ding et al.· iScience· 0 citations
Breast cancer is one of the leading causes of cancer death in women worldwide, making accurate and efficient early detection systems an urgent clinical need. Breast ultrasound (US) images offer a safe and affordable modality compared to mammography, but are susceptible to speckle noise and inter-observer variability th...
Gena Darma, Salsabila Rahayu Putri, Muhammad Rakha et al.· 2026 International Conferenc...· 0 citations
An enhanced deep learning framework for lung nodule segmentation and detection is proposed that combines an improved preprocessing pipeline, an attention-guided U-Net architecture, and a lightweight convolutional neural network (CNN) for classification.
B. Rajani, D. Reddy· International Conference on...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.